Santersus AG presented at Apheresis Conference at the University of California San Diego

At the end of February, Andrew Aswani, MD, PhD (Santersus AG Chief Medical Officer) participated in the 10th Annual UC San Diego Essentials & Advances in Apheresis Therapies. Dr. Aswani had the opportunity to share current success regarding Santersus and our development of the selective therapeutic cell-free DNA/NET apheresis device to a large audience of physicians and allied health professionals from all around the world, including both established practitioners and those embarking on a new apheresis service.

Related links

About Santersus

About VolitionRx Limited

If you would like to learn more about our technology, please contact Santersus team at